The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 23 formulations under Drugs (Price Control) order 2013. The price so fixed is exclusive of Goods and Services Tax (GST). The order for fixation of price was issued on 8th June, 2023.
The manufacturer may add GST only if they have paid actually or it is payable to the Government on the retail price of the formulation.
The manufacturer shall issue a price list in Form–V from date of Notification to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. Furthermore, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
The retail price fixed by this order is applicable only to the individual manufacturer / marketer as mentioned in the order i.e. who have applied for the same by submitting Form-I for price fixation / revision. The applicability of such retail price is also subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
In case the retail price of any of the formulations is not complied with, the concerned manufacturer/ marketing company shall be liable to deposit the overcharged amount along with the interest.
